Vertex Pharmaceuticals Incorporated (0QZU)
Market Closed
24 Feb, 15:30
$
488. 86
+2.89
+0.59%
$
114.85B Market Cap
30.83 P/E Ratio
- Div Yield
552 Volume
14.94 Eps
$ 485.97
Previous Close Day Range
478.14 490.99
Year Range
290.87 490.99
Want to track 0QZU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0QZU earnings report is expected in 69 days (4 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 4.42 | - |
| | | 4.41 | - |
| | | 5.15 | 4.65 |
| | | 5.14 | - |
| | | 4.58 | 4.2 |
| | | - | - |
| | | - | 2.49 |
| | | - | - |
| | | - | 4.01 |
| | | - | - |
| | | - | 4.21 |
| | | - | 4.21 |
| | | - | - |
| | | - | 3.97 |
0QZU Earnings Reports FAQ
What is the earnings per share (EPS) for 0QZU?
The current EPS is 14.94.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 8.2%, reflecting the 0QZU's performance and LSE market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-04, based on the 0QZU's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 4.6509 per share, reported on 2026-02-12. For dividend history, visit the 0QZU Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 105.11, calculated based on the most recent stock price of $488.86.
